SB 883 - Medical freedom for COVID care

SB 883, the Right to Treat Act, reinforces the right of doctors and patients to make medical decisions without government overreach. It allows doctors to prescribe FDA-approved medications for alternative, off-label uses to treat COVID-19, even if those uses aren’t officially listed on the drug label. This protects medical freedom and prevents the state from interfering in the doctor-patient relationship. By reducing bureaucratic red tape and shielding doctors from unjust punishment, the bill promotes efficiency in healthcare without expanding government. It also avoids costly lawsuits by clarifying that neither doctors nor manufacturers can be sued solely for using off-label treatments.